When results from the EMPA-REG OUTCOME trial came out, nobody was expecting empagliflozin to have a particularly robust benefit on heart failure and several questions were raised as a result, said ...

Treatment for heart failure with preserved ejection fraction (HFpEF) may soon resemble that for heart failure with reduced ejection fraction (HFrEF), noted Javed Butler, MD, MPH, MBA, of the ...

PASADENA, Calif., April 30, 2026 /PRNewswire/ -- Ventric Health, maker of the Vivio® System, the only FDA-cleared non-invasive device for measuring elevated left ventricular end-diastolic pressure, ...

Please provide your email address to receive an email when new articles are posted on . SGLT2 inhibitors and GLP-1 receptor agonists continue to demonstrate benefit for patients with heart failure.

May 3, 2023 | Javed Butler and C. Michael Gibson discuss using patiromer to manage hyperkalemia in patients with HFrEF who are taking RAAS inhibitors. Talking Points · Episode 174: The DIAMOND Trial ...

Please provide your email address to receive an email when new articles are posted on . As a physician and researcher specializing in the management and treatment of HF, Javed Butler, MD, MPH, MBA, ...

Dr. Javed Butler can describe the exact moment when he began the switch to hearts from livers. “I had wanted to be a hepatologist,” said Butler, who recently joined the University of Mississippi ...

Javed Butler, MD, MPH, MBA, recalls an early-career episode in which a mentor came to the hospital in the middle of the night to help him with an urgent case involving a young patient with postpartum ...